Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

85.95 -0.26 (-0.30%)
Streaming Delayed Price Updated: 2:57 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
47 48 Next >
Peering Into Medtronic's Recent Short Interest
Via Benzinga
Is Medtronic Stock a Buy Now?
This healthcare stock had a strong start to its fiscal 2024. 
Via The Motley Fool
Why Medtronic Stock Dropped Today
Medtronic gave up its post-earnings gains today after a lukewarm series of votes from the FDA on its Symplicity Spyral device. 
Via The Motley Fool
Exposures Product Safety
Investor Caution - Medtronic's Rocky Road Ahead For Hypertension Device
The FDA Circulatory System Devices Panel vote was closely divided on the benefit/risk profile of Medtronic Plc's (NYSE: MDT) device (tied at 6-6 and one abstention), with the panel chair breaking the... 
Via Benzinga
Exposures Product Safety
Boeing's 737 Deliveries Delay Due To Supplier Spirit Aerosystems, Petco Health and Wellness Stock Tumbles, AstraZeneca Under Legal Lens: Today's Top Stories
Benzinga 
Via Benzinga
Topics Supply Chain
Exposures Boeing 737 Supply Chain
Analyst Ratings for Medtronic
Via Benzinga
Medtronic Earnings Preview
Via Benzinga
3 Reasons to Buy Medtronic Stock
Despite serious headwinds, this healthcare giant is worth serious consideration. 
Via The Motley Fool
A Look Into Medtronic Inc's Price Over Earnings
Via Benzinga
Regulatory Setback For Medtronic's High Blood Pressure Device - FDA Backed Japanese Firms' Similar Device For Uncontrolled Hypertension
Medtronic Plc (NYSE: MDT) says the FDA Circulatory System Devices Panel (CSDP) voted unanimously (13-0) on safety and in favor (7-6) of the effectiveness of the Symplicity blood pressure procedure,  
Via Benzinga
Exposures Product Safety
Analysts Note Medtronic's Tummy Tuck Surgery Sales Unaffected Globally Amid Weight-Loss Treatment(s) Rush
William Blair writes that Medtronic Plc's (NYSE: MDT) Q1 FY24 witnessed a remarkable performance cascaded to the bottom line, amplified by improved gross margins due to better pricing discipline and... 
Via Benzinga
Why Medtronic Stock Was a Winner Today
The company notches a victory with an estimate-beating first quarter, and guidance that exceeded projections. 
Via The Motley Fool
Medtronic (MDT) Q1 2024 Earnings Call Transcript
MDT earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
S&P Slashes Ratings Of Five US Banks, SEC Fines Fintech Adviser Titan For Misleading Crypto Claims, Microsoft Modifies Activision Blizzard Purchase: Today's Top Stories
Benzinga 
Via Benzinga
Topics Regulatory Compliance Stocks
Exposures Legal Regulatory US Equities
Medtronic Beats Quarterly Expectations; Why It's Time To Embrace The 'Long-Term View'
The company has integrated numerous positive changes, says one analyst, who is watching Medtronic's "long-term view." 
Via Investor's Business Daily
Medtronic Lifts Annual Forecast On Better Than Expected Q1 Performance Across All Categories
Medtronic Plc's (NYSE: MDT) reported Q1 FY24 sales of $7.7 billion, up 4.5% Y/Y as reported and 6% organic, ahead of expectations, beating the  
Via Benzinga
US Stocks Set To Extend Rally As Fed Speeches, Nvidia Q2 Print Loom: Analyst Says 'Don't Panic' As Pullback Presents Buying Opportunity
After the lean patch seen last week, the stock market seems to have picked up momentum, riding on the hopes of a Fed pause. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Earnings Scheduled For August 22, 2023
Companies Reporting Before The Bell • BHP Group (NYSE:BHP) is estimated to report earnings for its Fiscal Year 2023. 
Via Benzinga
Medtronic Gears Up For Q1 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
Medtronic plc (NYSE: MDT) is expected to report financial results for its first quarter of fiscal year 2024, before the opening bell on Aug. 22, 2023. 
Via Benzinga
Poised For Rebound As Investors Await Fed Leader's Jackson Hole Address
(Monday market open) Given how the markets hang on every word spoken publicly by Federal Reserve Chair Jerome Powell, it only seems like he’s always speaking from a mountain top. This week, he will... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Artificial Intelligence in Diabetes Management Market Increasing Demand with Industry Professionals: Dexcom, Medtronic, One Drop
The Global Artificial Intelligence in Diabetes Management Market offers energetic visions to conclude market size, opportunities, growth pattern, and competitive surroundings. The research is derived... 
Via SBWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
A Look Ahead At Trading Week Aug. 21-25
Looking at the events of the upcoming trading week, including NVDA Earnings | Positive Gamma | ZM Earnings. 
Via Talk Markets
Stocks Turn Lower As China Weakness, Rising Yields Pressure Markets
(Friday market open) U.S. stocks are poised to decline for the fourth day in a row, setting up the S&P 500® Index (SPX) and Nasdaq Composite (COMP) for their third straight weekly drops as investors... 
Via Benzinga
What To Expect When Medtronic Reports Q1 Earnings Next Week
Medtronic Plc (NYSE: MDT) will report its Q1 FY24 earnings on Tuesday, 8/22/23. Needham provides a preview of its earnings report, including expectations for F1Q24 results, FY24 guidance, and... 
Via Benzinga
Got $2,000? 2 Cheap Stocks to Buy Right Now
If you have cash to put to work, here are two stocks that look cheap today and they'll pay you well to own them. 
Via The Motley Fool
7 Blue-Chip Stocks Smart Investors Should Be Loading Up on Now
These shares of blue-chip stocks to buy continue to be attractive for smart investors who value strong firms and steady performance. 
Via InvestorPlace
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval
Boston Scientific Corp (NYSE: BSX) will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European Society of Cardiology Congress on 27 August.... 
Via Benzinga
Exposures Product Safety
Jim Cramer Says Buy This Software And Major Cloud Stock: 'It's In The Bullpen'
Public Service Enterprise Group Incorporated (NYSE: PEG) has got a good yield and is a very solid company, according to Jim Cramer. 
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
7 Companies Leading the Way in Advanced AI and Robotics
Major tech stocks steal the headlines with AI and robotics, but these companies are using advanced tech under the radar. 
Via InvestorPlace
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.